Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
(Sharecast News) - GlaxoSmithKline shares shot higher on Thursday as it emerged that activist hedge fund Elliott Management has built a multibillion-pound stake in the pharmaceuticals company.
Read more
FRANKFURT, April 15 (Reuters) - German biotech firm CureVac said it would start testing its COVID-19 vaccine on adolescents as young as 12 at the end of the month, as it gets ready to publish initial efficacy results for adults in the second quar...
Read more
GlaxoSmithKline and Merck discontinue trials involving feladilimab
Read more(Adds Australian PM spokesman, UK health secretary comments)LONDON, April 8 (Reuters) - Hundreds of thousands of doses of the AstraZeneca vaccine have been flown to Australia from Britain but the source of the shipments was kept quiet to avoid any...
Read more(Adds source-based comments)LONDON, April 8 (Reuters) - Hundreds of thousands of doses of AstraZeneca vaccine have been flown to Australia from Britain but the source of the shipments was kept quiet to avoid any controversy in the United Kingdom, ...
Read more(Adds detail)LONDON, April 8 (Reuters) - Hundreds of thousands of doses of the AstraZeneca vaccine have been flown to Australia from the United Kingdom but the source of the shipments was kept quiet to avoid any controversy in the United Kingdom, ...
Read moreLONDON, April 7 (Reuters) - British Prime Minister Boris Johnson said he did not expect to change the government's plans for relaxing COVID-19 restrictions as health regulators recommended that people aged under 30 should not be given the AstraZe...
Read moreLONDON, April 7 (Reuters) - Blood clot side effects from the AstraZeneca COVID-19 vaccine are serious but vanishingly rare, England's deputy Chief Medical Officer Jonathan Van-Tam said on Wednesday."My final cautionary point for you is that this i...
Read moreLONDON, April 7 (Reuters) - British health officials said they did not know for sure that blood clot risks were directly associated with only one COVID-19 vaccine."This is an extremely rare adverse event, we do not know for sure that it's related ...
Read more* UK says 18-29 year olds should get other shots where possible* Oxford/AZ shot associated with rare cases of brain blood clots* Benefits outweigh the risks for vast majority, regulator says (Recasts headline and lead)By Guy Faulconbridge, Kate H...
Read more(Adds details on Europe's regulator, pace of rollout)LONDON, April 7 (Reuters) - Britain should not give Oxford/AstraZeneca's COVID-19 vaccine to under 30s where possible, Britain's Joint Committee on Vaccination and Immunisation (JCVI) said on We...
Read more(Recasts, adds detail)LONDON, April 7 (Reuters) - Britain should not give Oxford University/AstraZeneca's vaccine to under 30s where possible, Britain's Joint Committee on Vaccination and Immunisation (JCVI) said on Wednesday, due to a very rare s...
Read more* UK says 18-29 year olds should get other shots where possible* Oxford/AZ shot associated with rare cases of brain blood clots* Benefits outweigh the risks for vast majority, regulator says (Adds PM Johnson's reaction)By Guy Faulconbridge, Kate ...
Read moreLONDON, April 7 (Reuters) - Britain's recommendation against giving the Oxford-AstraZeneca COVID-19 vaccine to those aged under 30 due to the risk of blood clots will have a negligible impact on the vaccine programme, England's deputy chief medic...
Read moreLONDON, April 7 (Reuters) - People in Britain who have received their first dose of the AstraZeneca COVID-19 vaccine should continue to be offered their second dose, despite a change in guidance over administering the shot to younger citizens, he...
Read more
Last checked at